Interestingly, for a subset of the meningiomas in our cohort, we detected a significantly elevated level of 53BP1 foci in spheroids at day 2 post-EBRT, while for other samples, foci levels returned completely to control levels at this timepoint. This evidence concerns the gene TP53BP1 and meningioma.